QTc prolongation assessment in anticancer drug development: clinical and methodological issues

Cardiac safety assessments are commonly employed in the clinical development of investigational oncology medications. In anti-cancer drug development there has been increasing consideration for the potential of a compound to cause adverse electrocardiographic changes, especially QT interval prolonga...

Descripción completa

Detalles Bibliográficos
Autores principales: Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2009
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223992/
https://www.ncbi.nlm.nih.gov/pubmed/22275999
http://dx.doi.org/10.3332/ecancer.2009.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223992/
https://www.ncbi.nlm.nih.gov/pubmed/22275999
http://dx.doi.org/10.3332/ecancer.2009.130

Ejemplares similares